Acute myeloid leukemia (AML) is a subtype of leukemia which arises from the myeloid
cell lineage within the bone marrow. It is considered highly aggressive and difficult to treat,
with only approximately 55% of patients going...
Acute Myeloid Leukemia (AML) is the most common acute leukemia in adults and is
characterized by transformed hematopoietic progenitor cells that fail to reach terminal
differentiation, are continuously proliferating, and...
NAMI-A is a ruthenium based anti-metastatic agent currently in phase II clinical trials. Two derivatives, using 1-methyimidazole and 1-ethylimidazole, were synthesized and compared to NAMI-A to determine the effects of the ring...